ATAD1 and malaria: Given these challenges that are also associated with other promising vaccine candidates (AMA-1, MSP-1), development of a vaccine based on CyRPA, which is essential for the survival of the parasite and less prone to acquire sequence polymorphism, appears to be a positive step forward in our efforts of producing a highly effective malaria vaccine.